Targeting cancer metabolism: Therapeutic potential of the fatty acid synthase (FASN) inhibitors. - Nuzzo PV; Rodrigues S; Ribeiro CF; Teixeira IF; Fanelli GN; Bleve S; Ravera F; Pakula H; Pederzoli F; Nanus DM; Loda M (Critical reviews in oncology/hematology, 2025)